LA
GILD icon

Lifeworks Advisors’s Gilead Sciences GILD Stock Holding History

Lifeworks Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8M Buy
93,293
+19,031
+26% +$2.51M 1.23% 17
2026
Q1 		$10.3M Buy
74,262
+3,486
+5% +$488K 1.33% 13
2025
Q4 		$8.69M Sell
70,776
-8,695
-11% -$1.06M 1.12% 14
2025
Q3 		$8.82M Sell
79,471
-1,048
-1% -$119K 1.17% 17
2025
Q2 		$8.93M Buy
80,519
+53
+0.1% +$5.64K 1.33% 15
2025
Q1 		$9.02M Sell
80,466
-1,968
-2% -$203K 1.5% 12
2024
Q4 		$7.61M Buy
82,434
+5,315
+7% +$479K 1.37% 11
2024
Q3 		$6.47M Sell
77,119
-275
-0.4% -$21K 1.27% 17
2024
Q2 		$5.31M Buy
77,394
+6,991
+10% +$467K 1.48% 21
2024
Q1 		$5.16M Buy
70,403
+9,727
+16% +$748K 1.44% 16
2023
Q4 		$4.92M Buy
60,676
+4,111
+7% +$320K 1.7% 12
2023
Q3 		$4.24M Buy
56,565
+3,464
+7% +$266K 1.65% 13
2023
Q2 		$4.09M Buy
53,101
+11,343
+27% +$905K 1.74% 17
2023
Q1 		$3.46M Sell
41,758
-8,341
-17% -$691K 1.64% 13
2022
Q4 		$4.3M Buy
50,099
+881
+2% +$69.8K 2.42% 8
2022
Q3 		$3.86M Sell
49,218
-2,325
-5% -$147K 2.2% 10
2022
Q2 		$3.19M Buy
51,543
+46,437
+909% +$2.88M 2.02% 11
2022
Q1 		$304K Buy
+5,106
New +$326K 0.2% 97

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lifeworks Advisors's GILD Position: Q2 2026 in Review

Lifeworks Advisors increased its Gilead Sciences (GILD) stake by 26% in Q2 2026, buying an estimated $2.51M and bringing the position to 93,293 shares worth $11.8M. The position accounts for 1.23% of the portfolio, ranked #17.

Lifeworks Advisors first reported a position in GILD in Q1 2022 and has held it in 18 quarters since. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Lifeworks Advisors held 93,293 shares of Gilead Sciences worth $11.8M as of Q2 2026.
  • Lifeworks Advisors bought 19,031 Gilead Sciences shares in Q2 2026, an estimated $2.51M.
  • Gilead Sciences made up 1.23% of Lifeworks Advisors's portfolio in Q2 2026, its #17 holding.
  • Lifeworks Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 18 quarters since.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Lifeworks Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.